Brief Information of the Cell Line and Protein
Cell Line ID: CL000065 , HEK293-EBNA
Synonyms
293 c18
293c18
HEK 293 c18
HEK-293 c18
HEK293-EBNA1
HEK-293-EBNA
HEK 293-EBNA
HEK 293 EBNA
HEK293EBNA
293 EBNA
293-EBNA1
293-EBNA
293/EBNA
293EBNA
EBNA-293
EBNA293
293E
HEK293E
HEK/EBNA
HEK-EBNA
HEK.EBNA
293/EBNA-1
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_6974
Protein ID: PT00915 , Peroxisome proliferator-activated receptor gamma
Gene Name PPARG
Organism Homo sapiens, Human
Protein Classification Transcription factor
Uniprot ID P37231
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000065  Protein ID: PT00915
 
Compound ID Compound Name Compound Formula
CP0416268
3-[(1E)-1-[8-[(4-methyl-2-propylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C30H28N4O3
 1
1
EC50 = 2.4 nM
   TI
   LI
   LO
   TS
CP0492620
3-[(1E)-1-[8-[(2-propylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H26N4O3
 1
1
EC50 = 2.7 nM
   TI
   LI
   LO
   TS
CP0421190
3-[(1E)-1-[8-[(7-chloro-2-cyclopropylimidazo[1,2-a]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H22ClFN4O3
 1
1
EC50 = 3.6 nM
   TI
   LI
   LO
   TS
CP0472427
3-[(1E)-1-[8-[(8-chloro-2-cyclopropylimidazo[1,2-a]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H22ClFN4O3
 1
1
EC50 = 4.2 nM
   TI
   LI
   LO
   TS
CP0457474
3-[(1E)-1-[4-fluoro-8-[(2-propylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H25FN4O3
 1
1
EC50 = 4.4 nM
   TI
   LI
   LO
   TS
CP0468897
3-[(1E)-1-[8-[[7-chloro-2-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C28H22ClFN4O4
 1
1
EC50 = 5.3 nM
   TI
   LI
   LO
   TS
CP0391626
3-[(1E)-1-[8-[[8-chloro-2-(methoxymethyl)imidazo[1,2-a]pyridin-3-yl]methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C28H22ClFN4O4
 1
1
EC50 = 7.3 nM
   TI
   LI
   LO
   TS
CP0421187
3-[(1E)-1-[3-fluoro-8-[(2-propylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H25FN4O3
 1
1
EC50 = 7.4 nM
   TI
   LI
   LO
   TS
CP0421189
3-[(1E)-1-[8-[(6-chloro-2-cyclopropylimidazo[1,2-a]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H22ClFN4O3
 1
1
EC50 = 11 nM
   TI
   LI
   LO
   TS
CP0421186
3-[(1E)-1-[2-fluoro-8-[(2-propylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H25FN4O3
 1
1
EC50 = 12 nM
   TI
   LI
   LO
   TS
CP0471829
3-[(1E)-1-[8-[[4-(2-hydroxypropan-2-yl)-2-propylbenzimidazol-1-yl]methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C32H32N4O4
 1
1
EC50 = 13 nM
   TI
   LI
   LO
   TS
CP0391625
3-[(1E)-1-[8-[(2-cyclopropyl-7-fluoroimidazo[1,2-a]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H22F2N4O3
 1
1
EC50 = 13 nM
   TI
   LI
   LO
   TS
CP0440167
3-[(1E)-1-[8-[(2-ethylbenzimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C28H24N4O3
 1
1
EC50 = 17 nM
   TI
   LI
   LO
   TS
CP0468896
3-[(1E)-1-[8-[(2-cyclopropylimidazo[1,2-a]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H23FN4O3
 1
1
EC50 = 19 nM
   TI
   LI
   LO
   TS
CP0391624
3-[(1E)-1-[8-[(2-cyclopropylthieno[3,4-d]imidazol-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C27H21FN4O3S
 1
1
EC50 = 21 nM
   TI
   LI
   LO
   TS
CP0411178
3-[(1E)-1-[8-[(4-cyclopropyl-10-oxa-3,6-diazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7-tetraen-5-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C31H25FN4O4
 1
1
EC50 = 23 nM
   TI
   LI
   LO
   TS
CP0457475
3-[(1E)-1-[8-[(4-chloro-2-cyclopropylimidazo[4,5-c]pyridin-1-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C28H21ClFN5O3
 1
1
EC50 = 24 nM
   TI
   LI
   LO
   TS
CP0421188
3-[(1E)-1-[8-[(7-chloro-2-cyclopropylimidazo[4,5-b]pyridin-3-yl)methyl]-3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C28H21ClFN5O3
 1
1
EC50 = 32 nM
   TI
   LI
   LO
   TS
CP0416270
3-[(1E)-1-[8-[[4-(hydroxymethyl)-2-propylbenzimidazol-1-yl]methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C30H28N4O4
 1
1
EC50 = 33 nM
   TI
   LI
   LO
   TS
CP0473774
N-(2-hydroxyethyl)-1-[[(11E)-11-[1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)ethylidene]-6H-benzo[c][1]benzoxepin-8-yl]methyl]-2-propylbenzimidazole-4-carboxamide
   Show/Hide
C32H31N5O5
 1
1
EC50 = 57 nM
   TI
   LI
   LO
   TS
CP0158747
2,4-dichloro-N-(3,5-dichloro-4-quinolin-3-yloxyphenyl)benzenesulfonamide
   Show/Hide
C21H12Cl4N2O3S
 1
1
EC50 = 59 nM
   TI
   LI
   LO
   TS
CP0467726
3-[(1E)-1-[8-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H27N5O3
 1
1
EC50 = 84 nM
   TI
   LI
   LO
   TS
CP0560150
3-[(1E)-1-[3-[(4-methyl-2-propylbenzimidazol-1-yl)methyl]-5H-[1]benzoxepino[3,4-b]pyridin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H27N5O3
 1
1
EC50 = 86 nM
   TI
   LI
   LO
   TS
CP0416269
3-[(1E)-1-[8-[(4-phenyl-2-propylimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C31H28N4O3
 1
1
EC50 = 151 nM
   TI
   LI
   LO
   TS
CP0416271
ATx08-001
   Show/Hide
C21H23Cl2N3O3S
 1
1
EC50 = 163 nM
   TI
   LI
   LO
   TS
CP0492619
N-[1-[[(11E)-11-[1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)ethylidene]-6H-benzo[c][1]benzoxepin-8-yl]methyl]-2-propylbenzimidazol-4-yl]methanesulfonamide
   Show/Hide
C30H29N5O5S
 1
1
EC50 = 166 nM
   TI
   LI
   LO
   TS
CP0440166
3-[(1Z)-1-[6-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C30H29N5O2
 1
1
EC50 = 177 nM
   TI
   LI
   LO
   TS
CP0572822
2-ethyl-5,7-dimethyl-3-[[2-[1-(2H-tetrazol-5-yl)ethyl]-6-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl]methyl]imidazo[4,5-b]pyridine
   Show/Hide
C29H31N7
 1
1
EC50 = 197 nM
   TI
   LI
   LO
   TS
CP0572821
2-ethyl-5,7-dimethyl-3-[[(2Z)-2-[1-(2H-tetrazol-5-yl)ethylidene]-6-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl]methyl]imidazo[4,5-b]pyridine
   Show/Hide
C29H29N7
 1
1
EC50 = 251 nM
   TI
   LI
   LO
   TS
CP0566187
3-[(1E)-1-[8-[(2-propyl-4-pyridin-4-ylimidazol-1-yl)methyl]-6H-benzo[c][1]benzoxepin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C30H27N5O3
 1
1
EC50 = 593 nM
   TI
   LI
   LO
   TS
CP0041219
Actos
   Show/Hide
C19H20N2O3S
 1
1
EC50 = 2053 nM
   TI
   LI
   LO
   TS
CP0572798
3-[(1Z)-1-[8-[(4-methyl-2-propylbenzimidazol-1-yl)methyl]-5H-[1]benzoxepino[3,4-b]pyridin-11-ylidene]ethyl]-4H-1,2,4-oxadiazol-5-one
   Show/Hide
C29H27N5O3
 1
1
EC50 = 2194 nM
   TI
   LI
   LO
   TS
CP0876439
ARHALOFENATE
   Show/Hide
C19H17ClF3NO4
 1
1
EC50 = 7365 nM
   TI
   LI
   LO
   TS